Si è verificato un errore durante il caricamento della pagina.
Il nostro team è stato avvisato ma contattaci tramite il Widget assistenza email se il problema persiste.
Trend | Peers | Company |
---|---|---|
Is return on equity increasing? | Yes | No |
Is net profit margin increasing? | No | No |
Is asset turnover increasing? | No | Yes |
Is equity multiplier increasing? | No | Yes |
Competitors Used |
---|
Theragen Etex Co.,Ltd. |
JETEMA, Co., Ltd. |
Aprogen Biologics Inc. |
CMG Pharmaceutical Co., Ltd. |
KOREA PHARMA Co., Ltd. |
Return on Equity Benchmarks | ||||||||
Comparable Companies | ||||||||
A066700 | A216080 | A003060 | A058820 | A032300 | A002620 | |||
Return On Equity | ||||||||
Latest Twelve Months | -34% | 0% | -28% | 1% | 5% | -16% | ||
Fiscal Year - 1 | 20% | 22% | -30% | 3% | 0% | -5% | ||
Fiscal Year - 2 | 6% | 3% | 3% | 0% | -2% | -20% | ||
Fiscal Year - 3 | -4% | NA | 2% | NA | 12% | -1% | ||
Fiscal Year - 4 | -4% | NA | 3% | NA | 9% | 3% | ||
Fiscal Year - 5 | 40% | NA | -4% | 2% | 23% | -20% | ||
Average | 4% | 8% | -9% | 2% | 8% | -10% | ||
Median | 1% | 3% | -1% | 2% | 7% | -11% | ||
Benchmarks | Ticker | |||||||
Theragen Etex Co.,Ltd. | KOSDAQ:A066700 | |||||||
JETEMA, Co., Ltd. | KOSDAQ:A216080 | |||||||
Aprogen Biologics Inc. | KOSE:A003060 | |||||||
CMG Pharmaceutical Co., Ltd. | KOSDAQ:A058820 | |||||||
KOREA PHARMA Co., Ltd. | KOSDAQ:A032300 |
Financial Performance | ||||||||
Comparable Companies | ||||||||
(in millions) | A066700 | A216080 | A003060 | A058820 | A032300 | A002620 | ||
Latest Fiscal Year | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | ||
LTM Period | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | ||
Revenues | ||||||||
Latest Twelve Months | 249,625 | 68,520 | 67,378 | 99,100 | 81,277 | 779,822 | ||
Fiscal Year | 249,625 | 68,520 | 67,378 | 99,100 | 81,277 | 779,822 | ||
Fiscal Year - 1 | 216,470 | 58,716 | 87,364 | 93,907 | 83,240 | 804,043 | ||
Fiscal Year - 2 | 190,769 | 45,994 | 65,190 | 82,197 | 81,029 | 792,965 | ||
Fiscal Year - 3 | 166,567 | NA | 56,482 | NA | 79,577 | 762,568 | ||
Fiscal Year - 4 | 143,023 | NA | 53,320 | NA | 71,510 | 761,997 | ||
Fiscal Year - 5 | 138,083 | NA | 50,904 | 58,623 | 66,136 | 731,805 | ||
Net Income | ||||||||
Latest Twelve Months | (41,845) | (188) | (104,979) | 2,695 | 3,792 | (51,159) | ||
Fiscal Year | (41,845) | (188) | (104,979) | 2,695 | 3,792 | (51,159) | ||
Fiscal Year - 1 | 27,498 | 13,966 | (118,270) | 6,455 | 84 | (16,250) | ||
Fiscal Year - 2 | 11,038 | 1,455 | 12,639 | (388) | (1,119) | (74,556) | ||
Fiscal Year - 3 | (11,854) | NA | 8,103 | NA | 6,368 | (3,482) | ||
Fiscal Year - 4 | (8,968) | NA | 11,253 | NA | 3,159 | 11,431 | ||
Fiscal Year - 5 | 43,646 | NA | (8,315) | 3,051 | 5,528 | (90,492) | ||
Total Assets | ||||||||
Latest Fiscal Quarter Prior | 243,135 | 236,768 | 589,397 | 242,098 | 121,303 | 879,997 | ||
Latest Fiscal Quarter | 237,003 | 222,717 | 590,984 | 303,437 | 112,387 | 890,433 | ||
Fiscal Year | 237,003 | 222,717 | 590,984 | 303,437 | 112,387 | 890,433 | ||
Fiscal Year - 1 | 243,135 | 236,768 | 589,397 | 242,098 | 121,303 | 879,997 | ||
Fiscal Year - 2 | 246,553 | 188,354 | 684,140 | 213,260 | 130,947 | 865,677 | ||
Fiscal Year - 3 | 350,073 | NA | 614,621 | NA | 129,401 | 892,421 | ||
Fiscal Year - 4 | 534,886 | NA | 615,309 | NA | 81,320 | 887,395 | ||
Fiscal Year - 5 | 241,498 | NA | 365,283 | 192,243 | 66,747 | 845,285 | ||
Fiscal Year - 6 | 174,678 | NA | 217,062 | 114,380 | 62,231 | 920,086 | ||
Common Equity | ||||||||
Latest Fiscal Quarter Prior | 135,701 | 71,512 | 368,691 | 190,233 | 68,582 | 319,461 | ||
Latest Fiscal Quarter | 112,146 | 72,284 | 378,491 | 189,542 | 71,441 | 306,950 | ||
Fiscal Year | 112,146 | 72,284 | 378,491 | 189,542 | 71,441 | 306,950 | ||
Fiscal Year - 1 | 135,701 | 71,512 | 368,691 | 190,233 | 68,582 | 319,461 | ||
Fiscal Year - 2 | 143,598 | 56,947 | 426,521 | 184,953 | 59,815 | 337,765 | ||
Fiscal Year - 3 | 222,697 | NA | 507,939 | NA | 57,467 | 411,731 | ||
Fiscal Year - 4 | 374,121 | NA | 505,395 | NA | 46,502 | 407,452 | ||
Fiscal Year - 5 | 135,862 | NA | 246,343 | 180,158 | 26,598 | 393,208 | ||
Fiscal Year - 6 | 80,918 | NA | 150,511 | 103,982 | 22,241 | 490,334 |